drugset / Trial / NCT05509543

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

NCT05509543

Phase 1 Completed 60 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluate the pharmacokinetic and safety of IY-NT-T in healthy adults

Timeline

Start
2022-08-24
Primary completion
2022-10-22
Completion
2023-12-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ilaprazole Small molecule 10 mg
Comparator Ilaprazole Small molecule 20 mg

Indications

No indication recorded.